How Will AI-First Drug Design Transform Human Health? As seen in BioTechnique

AlphaFold changed everything. But what happens when you build an entire drug discovery company around that kind of technology from day one?

At ELRIG Drug Discovery 2025, BioTechniques sat down with Miles Congreve, Chief Scientific Officer at Isomorphic Labs, the company founded by Nobel laureate Demis Hassabis. Miles has spent 30 years in drug discovery and has been involved in getting 29 drugs into the clinic. He knows what the old way looks like and he has a very clear view of what the new way could mean for human health.

In this interview, he talks honestly about the real challenges of building AI tools that actually work in practice, what it takes to put the right team together, and why he believes the world his 13-year-old daughter grows up into will look very different from ours.